课题基金 / 基金详情

Systems Genetic Analysis of Methamphetamine's Motivational Effects in a Mouse AIL

Systems Genetic Analysis of Methamphetamine's Motivational Effects in a Mouse AIL
甲基苯丙胺对小鼠 AIL 的激励作用的系统遗传学分析
批准号:
9195288
负责人:
ABRAHAM A PALMER
金额:
$8.81万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-01-01 至 2017-03-31

项目摘要

项目成果

ABRAHAM A PALMER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We propose a multidisciplinary, translational genetic study to identify genes that influence sensitivity to the stimulant drugs methamphetamine and amphetamine in mice and humans. We will use mice to better define chromosomal regions (also called quantitative trait loci or QTL) that contain genes that influence sensitivity to the acute locomotor stimulant effects of methamphetamine. This will be accomplished using two complimentary approaches: congenic strains, and advanced intercross lines. Using these techniques, we will be able to determine, with some precision, the location of genes that influence this trait. We will then use a variety of experimental and bioinformatic approaches to parse among the genes located in those regions, which will allow us to identify a small number of high probability candidate genes. We expect that this list of genes will include those responsible for differences in the response to methamphetamine in the mice. We will then explore the effect of polymorphisms in these genes on the subjective response to amphetamine in a sample of carefully screened, healthy human volunteers. All volunteers will give informed consent prior to participation in the study. We will use a double-blind, within-subject design in which each subject receives each dose (placebo, 5,10 and 20 mg) of amphetamine once, in a randomized order, over the course of 4 sessions. During the sessions when drug or placebo has been administered, subjects will self-report their emotional and cognitive experiences, which are expected to include a subjective feeling of being under the influence of a drug, as well as varying degrees of euphoria and anxiety. We will also evaluate their performance on behavioral tasks, and record physiological data over the course of the sessions. We will then examine the relationship between the response to amphetamine and polymorphisms in the genes selected in the mouse studies. We expect that some of the genes have polymorphisms that are associated with, and may cause, differences in the response to amphetamine among the human volunteers. We believe that differences in the acute response to stimulant drugs like amphetamine, methamphetamine and cocaine are important for determining the genetic risk for the development of drug abuse. Identification of these genes may be useful for developing new therapeutic strategies to treat or prevent drug abuse and addiction.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
Inattention, impulsive action, and subjective response to D-amphetamine.
注意力不集中、冲动行为以及对 D-安非他明的主观反应。
DOI: 10.1016/j.drugalcdep.2013.05.021
发表时间: 2013
期刊: Drug and alcohol dependence
影响因子: 4.2
作者: [Weafer,Jessica, deWit,Harriet]
通讯作者: deWit,Harriet
More on ADORA.
更多关于阿多拉的信息。
DOI: 10.1007/s00213-010-2003-8
发表时间: 2010
期刊: Psychopharmacology
影响因子: 3.4
作者: [Yang,Amy, Childs,Emma, Palmer,AbrahamA, deWit,Harriet]
通讯作者: deWit,Harriet
Modulation ofTcf7l2 expression alters behavior in mice.
Tcf7l2 表达的调节会改变小鼠的行为。
DOI: 10.1371/journal.pone.0026897
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者: [Savic,Daniel, Distler,MargaretG, Sokoloff,Greta, Shanahan,NancyA, Dulawa,StephanieC, Palmer,AbrahamA, Nobrega,MarceloA]
通讯作者: Nobrega,MarceloA
Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology.
对 d-安非他明的峰值积极主观反应时间的个体差异:与药代动力学和生理学的关系。
DOI: 10.1177/0269881116631650
发表时间: 2016
期刊: Journal of psychopharmacology (Oxford, England)
影响因子: --
作者: [Smith,ChristopherT, Weafer,Jessica, Cowan,RonaldL, Kessler,RobertM, Palmer,AbrahamA, deWit,Harriet, Zald,DavidH]
通讯作者: Zald,DavidH
10
    A Novel Pharmacotherapy for Alcoholism: Evaluation of Reward, Aversion, Compulsivity, Withdrawal & Reinstatement
    A Novel Pharmacotherapy for Alcoholism: Evaluation of Reward, Aversion, Compulsivity, Withdrawal & Reinstatement
    A Novel Pharmacotherapy for Alcoholism: Evaluation of Reward, Aversion, Compulsivity, Withdrawal & Reinstatement
    A Novel Pharmacotherapy for Alcoholism: Evaluation of Reward, Aversion, Compulsivity, Withdrawal & Reinstatement
    海外基金